EuroEyes International Eye Clinic Limited provided earnings guidance for the six months ended 30 June 2023. For the period, the Group expected to record a profit attributable to owners of the Company in the range of HKD 66 million to HKD 70 million as compared to that of the corresponding period in 2022, a profit attributable to owners of the Company in the amount of approximately HKD 46.5 million, representing an increase of approximately 42%.
EuroEyes International Eye Clinic Limited
Equities
1846
KYG3224D1088
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.95 HKD | +3.12% | +5.54% | -4.99% |
Apr. 26 | EuroEyes International to Buy Back Up to 3% Shares | MT |
Apr. 24 | EuroEyes International Logs 6% Growth in Q1 Eye Surgeries | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.99% | 211M | |
-21.25% | 2.91B | |
-20.94% | 2.67B | |
-60.16% | 2.06B | |
-25.10% | 323M | |
-47.38% | 172M | |
-27.37% | 123M |
- Stock Market
- Equities
- 1846 Stock
- News EuroEyes International Eye Clinic Limited
- EuroEyes International Eye Clinic Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023